Literature DB >> 16048978

First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.

K Lolans1, A M Queenan, K Bush, A Sahud, J P Quinn.   

Abstract

Carbapenemases are rare in the United States. This is the first report of a United States nosocomial outbreak of pan-resistant Pseudomonas aeruginosa infections due to an integron-borne metallo-beta-lactamase, VIM-2. This emergence of carbapenemases on mobile genetic elements in the United States warrants surveillance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16048978      PMCID： PMC1196250          DOI： 10.1128/AAC.49.8.3538-3540.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

3.  Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7).

Authors:  Alan Patrick Gibb; Chanwit Tribuddharat; Richard A Moore; Thomas J Louie; Wally Krulicki; David M Livermore; Marie-France I Palepou; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.

Authors:  Mark A Toleman; Alan M Simm; Tanya A Murphy; Ana C Gales; Doug J Biedenbach; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

5.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.

Authors:  G Cornaglia; A Mazzariol; L Lauretti; G M Rossolini; R Fontana
Journal:  Clin Infect Dis       Date:  2000-11-06       Impact factor: 9.079

Review 7.  Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support.

Authors:  L Poirel; P Nordmann
Journal:  Curr Pharm Biotechnol       Date:  2002-06       Impact factor: 2.837

8.  Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4.

Authors:  S Pournaras; M Maniati; E Petinaki; L S Tzouvelekis; A Tsakris; N J Legakis; A N Maniatis
Journal:  J Antimicrob Chemother       Date:  2003-04-25       Impact factor: 5.790

Review 9.  Properties and potential of ertapenem.

Authors:  David M Livermore; Armine M Sefton; Geoffrey M Scott
Journal:  J Antimicrob Chemother       Date:  2003-08-13       Impact factor: 5.790

10.  Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Authors:  Timothy R Walsh; Anne Bolmström; Anette Qwärnström; Ana Gales
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more
  51 in total

Review 1.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.

Authors:  Gina K Thomson; James W Snyder; Christi L McElheny; Kenneth S Thomson; Yohei Doi
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

3.  Evaluation of the Check-Points Check MDR CT103 and CT103 XL Microarray Kits by Use of Preparatory Rapid Cell Lysis.

Authors:  Scott A Cunningham; Shawn Vasoo; Robin Patel
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

4.  First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.

Authors:  Nancy D Hanson; Ashfaque Hossain; Larry Buck; Ellen Smith Moland; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia.

Authors:  Maria Virginia Villegas; Karen Lolans; Maria del Rosario Olivera; Carlos José Suarez; Adriana Correa; Anne Marie Queenan; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  Detection of gene cassettes in Tn402-like class 1 integrons.

Authors:  Virginia Post; Gavin D Recchia; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

7.  Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay.

Authors:  Nicholas M Moore; Rafael Cantón; Edoardo Carretto; Lance R Peterson; Robert L Sautter; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

Review 8.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Marta Tato; Teresa M Coque; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

10.  Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Kai-Tai Chang; Kamilia Abdelraouf; Cristina G Brioso; Magdalene Ameka; Laurie A McCaskey; Jaye S Weston; Juan-Pablo Caeiro; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.